|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 800 Maine AVE SW, Suite 900 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20024-2002 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 3151-12
|
||||||||
|
6. House ID# 304890000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Craig Obey |
Date | 10/21/2019 4:51:35 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 2740, FY 2020 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bill, including programs and initiatives related to mental health and substance use disorders operated by HHS, NIH, SAMHSA, CDC, HRSA
H.R. 2500 National Defense Authorization Act
FY 2020 MilCon-VA Appropriations Bill
H.R. 2021 the Investing for the People Act of 2019
H.R. 3164, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Deana |
McRae |
|
|
|
Mike |
Troubh |
|
|
|
Kaileen |
Dougherty |
|
|
|
Craig |
Obey |
|
|
|
Michelle |
Greenhalgh |
|
|
|
Tim |
Clement |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
H.R. 5, the Equality Act
Sec. 1557 of the ACA, Efforts to weaken nondiscrimination protections for lesbian, gay, bisexual, transgender, and questioning (LGBTQ) individuals
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mike |
Troubh |
|
|
|
Kaileen |
Dougherty |
|
|
|
Deana |
McRae |
|
|
|
Craig |
Obey |
|
|
|
Michelle |
Greenhalgh |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
H.R. 8 Bipartisan Background Checks Act of 2019
H.R. 1112 Enhanced Background Checks Act of 2019
ERPO
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Institutes of Health (NIH), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kaileen |
Dougherty |
|
|
|
Craig |
Obey |
|
|
|
Mike |
Troubh |
|
|
|
Michelle |
Greenhalgh |
|
|
|
Tim |
Clement |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R.1763 / S. 348, the Resident Physician Shortage Reduction Act of 2019
H.R. 2062 / S. 1012 (42 CFR Part 2)
H.R. 1585, the Violence Against Women Reauthorization Act
H.R. 5, the Equality Act
H.R. 1109, the Mental Health Services for Students Act of 2019
S. 824, the Excellence in Mental Health and Addiction Treatment Expansion Act
H.R. 2300 Eliminating Debtor's Prison for Kids Act of 2019
Activity to promote evidence-based trauma-informed care
Out of network billing legislation
H.R. 2569/S. 1365, the CARE Act
H.R. 3414, the Opioid Workforce Act
S. 1895, the Lower Health Care Costs Act
H.R. 3496, the CREATE Opportunities Act
S. 1227, the Prescription Pricing for the People Act of 2019
H.R. 2874 / S. 1576, the Behavioral Health Coverage Transparency Act
S.1659, the Ensuring Childrens Access to Specialty Care Act of 2019
H.R. 3253, the Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act
H.R. 1554, the Resident Education Deferred Interest Act
H.R. 3239, the Humanitarian Standards for Individuals in Customs and Border Protection Custody Act
H.R. 3180/ S. 1770, the RISE from Trauma Act
H.R. 2862, the VACCINES Act of 2019
H.R. 4309, the Barriers to Suicide Act
H.R. 2569/S. 1365, the Comprehensive Addiction Resources Emergency (CARE) Act
H.R. 2279, the Safe Step Act
H.R. 4327, the Enhancing Mental Health and Suicide Prevention Through Campus Planning Act
H.R. 3735, the Law Enforcement Suicide Data Collection Act
H.R. 3417, BETTER Act of 2019
H. Res. 337, Expressing support for the designation of May 2019 as "Mental Health Awareness Month
H. Res. 587, Recognizing LGBTQ+ suicide as a public health problem and expressing support for the designation of September as "National Suicide Prevention Month"
H. Res. 480, Acknowledging the racial disparities in diagnosing and treating mental health among youth in communities of color
S. 1227, the Prescription Pricing for the People Act of 2019
H.R. 3, Lower Drug Costs Now Act of 2019
H.R. 2734 / S. 1448, the Safer Prescribing of Controlled Substances Act
H.R. 2482/ S. 2074, the Mainstreaming Addiction Treatment Act of 2019
Title X Family Planning Program Administration Rule
Maternal mortality legislation
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mike |
Troubh |
|
|
|
Kaileen |
Dougherty |
|
|
|
Deana |
McRae |
|
|
|
Craig |
Obey |
|
|
|
Andrew |
Strickland |
|
|
|
Tim |
Clement |
|
|
|
Michelle |
Greenhalgh |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Issues relating to new legislative attempt to increase compliance with the Mental Health Parity and Addiction Equity Act of 2008
H. Res. 271, Condemning the Trump Administration's Legal Campaign to Take Away Americans' Health Care
H.R. 3165 / S. 1737, the Mental Health Parity Compliance Act
H.R. 2279, the Safe Step Act
H.R. 1010 re: Short-Term, Limited Duration Insurance
H.R. 986, the Protecting Americans with Preexisting Conditions Act of 2019
H.R. 1425, the State Health Care Premium Reduction Act
H.R. 987, the Marketing and Outreach Restoration to Empower (MORE) Health Education Act of 2019
H.R. 3630, the No Surprises Act
H.R. 2874/ S. 1576, the Behavioral Health Coverage Transparency Act of 2019
H.R. 3107, the Improving Seniors Timely Access to Care Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mike |
Troubh |
|
|
|
Craig |
Obey |
|
|
|
Tim |
Clement |
|
|
|
Kaileen |
Dougherty |
|
|
|
Andrew |
Strickland |
|
|
|
Deana |
McRae |
|
|
|
Michelle |
Greenhalgh |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1329, the Medicaid Reentry Act
H.R. 1839, the Medicaid Services Investment and Accountability Act of 2019
H.R. 1767 Excellence in Mental Health and Addiction Treatment Expansion Act
H.R. 3925, the Reducing Barriers to Substance Use Treatment Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kaileen |
Dougherty |
|
|
|
Mike |
Troubh |
|
|
|
Craig |
Obey |
|
|
|
Michelle |
Greenhalgh |
|
|
|
Deana |
McRae |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1109, Mental Health Services for Students Act
STOP School Violence Act FY20 Funding
S. 1782 Improving Mental Health Access for Students Act
H.R. 2599/ S. 2492 Suicide Training and awareness nationally delivered for universal prevention act (STAND UP Act)
H.R. 2431 / S. 2550, the Mental Health Professionals Workforce Shortage Loan Repayment Act of 2019
H.R. 3414, the Opioid Workforce Act of 2019
H.R. 2443, the Investment in Tomorrow's Pediatric Health Care Workforce Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kaileen |
Dougherty |
|
|
|
Craig |
Obey |
|
|
|
Mike |
Troubh |
|
|
|
Michelle |
Greenhalgh |
|
|
|
Deana |
McRae |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
H. Res. 124, RE: military transgender ban
H.R. 2767, Supporting Eating disorders Recovery through Vital Expansion Act
S. 1467, Sergeant Daniel Somers Network of Support Act
H.R. 2500 National Defense Authorization Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Defense - Dept of (DOD), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Deana |
McRae |
|
|
|
Craig |
Obey |
|
|
|
Mike |
Troubh |
|
|
|
Michelle |
Greenhalgh |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 1963, the Expanding Care for Veterans Act
H.R. 1674, the Veterans Improved Access and Care Act
H.R. 712/S 179: the VA Medicinal Cannabis Research Act
S. 785, the Commander John Scott Hannon Veterans Mental Health Care Improvement Act of 2019
H.R. 2931 SERVE Act of 2019
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Deana |
McRae |
|
|
|
Mike |
Troubh |
|
|
|
Craig |
Obey |
|
|
|
Michelle |
Greenhalgh |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 3239 / S. 2135, the Humanitarian Standards for Individuals in CBP Custody Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Craig |
Obey |
|
|
|
Mike |
Troubh |
|
|
|
Michelle |
Greenhalgh |
|
|
|
Deana |
McRae |
|
|
|
Kaileen |
Dougherty |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
IMM |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |